Serum S100B Levels and Major Depressive Disorder: Its Characteristics and Role in Antidepressant Response

Abstract

The results of this study suggest that the baseline serum S100B level is associated with the subsequent response to antidepressants. In addition, the high baseline serum S100B level that was observed in depressive patients may enhance neuroplasticity, which results in a favorable therapeutic response to antidepressants.